Bulletin
Investor Alert

New York Markets Open in:

Bristol-Myers Squibb Co.

NYS: BMY

GO
/marketstate/country/us

Before the Bell

BMY
/zigman2/quotes/202559280/composite

$

64.16

Change

+0.19 +0.30%

Volume

Volume 1,096

Feb 25, 2020, 8:46 a.m.

Real time quotes

/zigman2/quotes/202559280/composite

Previous close

$ 63.97

$ 63.97

Change

-1.66 -2.53%

Day low

Day high

$63.69

$65.06

Open
Open: 64.08

52 week low

52 week high

$42.48

$68.34

Open

Market cap

$149.96B

Average volume

13.27M

P/E ratio

29.12

Rev. per Employee

$968,283

EPS

2.20

Dividend

0.41

Div yield

2.81%

Ex dividend date

7/3/19

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bmy

MarketWatch News on BMY

  1. 12 Stock Picks That Will Please Both Growth and Value Investors

    8:00 a.m. Feb. 18, 2020

    - Nicholas Jasinski

  2. Bristol-Myers Just Reported Earnings. Its Stock Is Jumping.

    8:29 a.m. Feb. 6, 2020

    - Josh Nathan-Kazis

  3. Bristol-Myers Squibb 2020 FactSet EPS consensus $6.12; revenue $42.2 bln

    7:31 a.m. Feb. 6, 2020

    - Ciara Linnane

  4. Bristol-Myers Squibb now sees 2020 revenue $40.5 bln to $42.5 bln

    7:30 a.m. Feb. 6, 2020

    - Ciara Linnane

  5. Bristol-Myers Squibb now sees 2021 adj. EPS $7.15 to $7.45

    7:29 a.m. Feb. 6, 2020

    - Ciara Linnane

  6. Bristol-Myers Squibb now sees 202 adj. EPS $6.00 to $6.20

    7:29 a.m. Feb. 6, 2020

    - Ciara Linnane

  7. Bristol-Myers Squibb now sees 202 EPS 75 cents to 95 cents

    7:28 a.m. Feb. 6, 2020

    - Ciara Linnane

  8. Bristol-Myers Squibb Q4 revenue $7.945 bln vs. $5.973 bln; FactSet consensus $7.120 bln

    7:27 a.m. Feb. 6, 2020

    - Ciara Linnane

  9. Bristol-Myers Squibb Q4 adj. EPS $1.22; FactSet consensus 88 cents

    7:27 a.m. Feb. 6, 2020

    - Ciara Linnane

  10. Bristol-Myers Squibb Q4 loss per share 55 cents vs. EPS 71 cents

    7:27 a.m. Feb. 6, 2020

    - Ciara Linnane

  11. Merck Reports Earnings Tomorrow. Here’s What to Expect.

    7:30 a.m. Feb. 4, 2020

    - Josh Nathan-Kazis

  12. Alphabet, Uber, Disney and Other Stocks to Watch This Week

    3:00 p.m. Feb. 2, 2020

    - Nicholas Jasinski

  13. Why Netflix Needs Those Oscar Nominations

    8:00 p.m. Jan. 31, 2020

    - Evie Liu

  14. This Earnings Season Is Better Than You Think

    6:29 p.m. Jan. 31, 2020

    - Jack Hough

  15. Amgen Stock Falls on a Weaker-Than-Expected Outlook

    8:52 a.m. Jan. 31, 2020

    - Josh Nathan-Kazis

  16. Amgen Reports Earnings Tomorrow. Here’s What to Expect.

    7:00 a.m. Jan. 29, 2020

    - Josh Nathan-Kazis

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bmy

Other News on BMY

  1. 10-K: BRISTOL MYERS SQUIBB CO

    4:13 p.m. Feb. 24, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. My 19 Best Dividend Ideas For 2020

    10:33 a.m. Feb. 24, 2020

    - Seeking Alpha

  3. Sanders' big Nevada primary win shakes health-related stocks

    10:10 a.m. Feb. 24, 2020

    - Seeking Alpha

  4. Bouncing Biotechs: A Multi-Company Review

    9:53 a.m. Feb. 24, 2020

    - Seeking Alpha

  5. Bristol-Myers study expansions triggers $10M payment to CytomX

    8:16 a.m. Feb. 24, 2020

    - Seeking Alpha

  6. Cowen & Co. Keeps Their Hold Rating on Bristol Myers (BMY)

    12:13 a.m. Feb. 24, 2020

    - SmarterAnalyst

  7. Tracking George Soros' Portfolio - Q4 2019 Update

    11:35 a.m. Feb. 21, 2020

    - Seeking Alpha

  8. Ronald Muhlenkamp's Firm Buys 3 Stocks in 4th Quarter

    11:13 a.m. Feb. 21, 2020

    - GuruFocus.com

  9. Dems attack Trump over stalled efforts to lower drug prices

    9:32 a.m. Feb. 21, 2020

    - Seeking Alpha

  10. SPY: Why Stocks Are Headed Higher From Here

    11:39 p.m. Feb. 20, 2020

    - Seeking Alpha

  11. NASH: The Second Wave

    6:29 p.m. Feb. 20, 2020

    - Seeking Alpha

  12. David Abrams Buys 2 Stocks in 4th Quarter

    11:37 a.m. Feb. 20, 2020

    - GuruFocus.com

  13. VBL Therapeutics announces new study of VB-111 in CRC

    11:25 a.m. Feb. 20, 2020

    - Seeking Alpha

  14. What's in Store for Jounce (JNCE) This Earnings Season?

    10:31 a.m. Feb. 20, 2020

    - Zacks.com

  15. Compugen readies study of COM701 triplet therapy in cancer

    8:28 a.m. Feb. 20, 2020

    - Seeking Alpha

  16. At This Point, Even the Coronavirus Can’t Save MMM Stock

    8:10 a.m. Feb. 20, 2020

    - InvestorPlace.com

  17. 15 Top ESG Stocks That Look Undervalued for 2020

    7:04 a.m. Feb. 20, 2020

    - 247WallSt.com

  18. Loading more headlines...
/news/pressrelease/company/us/bmy

Press Releases on BMY

  1. The Top Companies Benefiting from the Global Coronavirus Outbreak

    5 min ago

    - Baystreet.ca

  2. At 5.5% CAGR, Cancer Biological Therapy Market Size to Surpass USD 59.9 Billion by 2025

    7:15 a.m. Today

    - Brandessence Market Research

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.